Enabling Remote Personalised Care for Immune-Mediated Diseases
NimBio has raised $880K in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2022.
NimBio's investors include eHealth Ventures.
NimBio is headquartered in Amsterdam, The Netherlands.
Enabling Remote Personalised Care for Immune-Mediated Diseases
NimBio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NimBio — Funding & Investors." VCBacked, November 10, 2022, https://www.vcbacked.co/company/nimbio. Accessed August 15, 2026.
VCBacked. (2022). NimBio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/nimbio
{{cite web |title=NimBio — Funding & Investors |url=https://www.vcbacked.co/company/nimbio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated